Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T41239
|
|||||
Target Name |
Hydroxyapatite (HA)
|
|||||
Gene Name |
NOUNIPROTAC
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Calcific uremic arteriolopathy [ICD-11: EB90] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | SNF472 | Drug Info | Phase 3 | Calciphylaxis | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Binder | [+] 1 Binder drugs | + | ||||
1 | SNF472 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Sanifit. | |||||
REF 2 | ClinicalTrials.gov (NCT04195906) Phase 3 Study of SNF472 for Calciphylaxis (Calciphyx). U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.